Upstream Bio (UPB) Equity Ratio (2023 - 2026)

Upstream Bio's Equity Ratio history runs 4 years deep, the most recent figure standing at 0.96 for Q1 2026.

• In Q1 2026, Equity Ratio fell 2.16% year-over-year to 0.96; the TTM figure through Mar 2026 stood at 0.96 (down 2.16% YoY), while the FY2025 annual figure was 0.96, down 1.53% from the prior year.
• Equity Ratio was 0.96 for Q1 2026 at Upstream Bio, roughly flat from 0.96 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.98 in Q1 2025 to a low of 1.05 in Q4 2023.
• Historically, Equity Ratio has averaged 0.51 across 4 years, with a median of 0.96 in 2025.
• The sharpest annual moves came in 2025 and 2026: Equity Ratio jumped 240.48% in 2025, then fell 2.16% in 2026.
• A 4-year view of Equity Ratio shows it stood at 1.05 in 2023, then surged by 192.84% to 0.98 in 2024, then declined by 1.53% to 0.96 in 2025, then decreased by 0.48% to 0.96 in 2026.
• The last three Equity Ratio figures came in at 0.96 (Q1 2026), 0.96 (Q4 2025), and 0.97 (Q3 2025), per Business Quant data.